HEADER TRANSFERASE 11-AUG-05 2AN4 TITLE STRUCTURE OF PNMT COMPLEXED WITH S-ADENOSYL-L-HOMOCYSTEINE AND THE TITLE 2 ACCEPTOR SUBSTRATE OCTOPAMINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: PHENYLETHANOLAMINE N-METHYLTRANSFERASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PNMTASE, NORADRENALINE N-METHYLTRANSFERASE; COMPND 5 EC: 2.1.1.28; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PNMT; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)PLYSS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET17PNMT-HIS KEYWDS METHYLTRANSFERASE, SUBSTRATE STRUCTURE, S-ADENOSYL-L-METHIONINE, KEYWDS 2 ADRENALINE SYNTHESIS, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR C.L.GEE,J.D.A.TYNDALL,G.L.GRUNEWALD,Q.WU,M.J.MCLEISH,J.L.MARTIN REVDAT 4 25-OCT-23 2AN4 1 REMARK SEQADV REVDAT 3 13-JUL-11 2AN4 1 VERSN REVDAT 2 24-FEB-09 2AN4 1 VERSN REVDAT 1 14-MAR-06 2AN4 0 JRNL AUTH C.L.GEE,J.D.A.TYNDALL,G.L.GRUNEWALD,Q.WU,M.J.MCLEISH, JRNL AUTH 2 J.L.MARTIN JRNL TITL MODE OF BINDING OF METHYL ACCEPTOR SUBSTRATES TO THE JRNL TITL 2 ADRENALINE-SYNTHESIZING ENZYME PHENYLETHANOLAMINE JRNL TITL 3 N-METHYLTRANSFERASE: IMPLICATIONS FOR CATALYSIS JRNL REF BIOCHEMISTRY V. 44 16875 2005 JRNL REFN ISSN 0006-2960 JRNL PMID 16363801 JRNL DOI 10.1021/BI051636B REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.94 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 43059 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.229 REMARK 3 FREE R VALUE : 0.274 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.100 REMARK 3 FREE R VALUE TEST SET COUNT : 4343 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.004 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.28 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3812 REMARK 3 BIN R VALUE (WORKING SET) : 0.4180 REMARK 3 BIN FREE R VALUE : 0.4330 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.30 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 439 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.021 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4103 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 79 REMARK 3 SOLVENT ATOMS : 254 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 47.21 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -6.25600 REMARK 3 B22 (A**2) : -6.25600 REMARK 3 B33 (A**2) : 12.51100 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.32 REMARK 3 ESD FROM SIGMAA (A) : 0.47 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.38 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.55 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.00 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.950 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ANISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : 47.84 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : SAH_MOD2.PARAM REMARK 3 PARAMETER FILE 4 : OCT.PARAM REMARK 3 PARAMETER FILE 5 : ION.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2AN4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 16-AUG-05. REMARK 100 THE DEPOSITION ID IS D_1000034087. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-SEP-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : OSMIC MIRRORS (MAXSCREEN) REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : D*TREK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 43061 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 41.940 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 6.950 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.99 REMARK 200 R MERGE FOR SHELL (I) : 0.44700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: PDB ENTRY 1HNN REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 60.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.10 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 6000, LICL, CACODYLATE, PH 5.8, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 93.87000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 46.73500 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 46.73500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 140.80500 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 46.73500 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 46.73500 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 46.93500 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 46.73500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 46.73500 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 140.80500 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 46.73500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 46.73500 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 46.93500 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 93.87000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE ENZYME IS ACTIVE AS A MONOMER REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 2010 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20010 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -4.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 GLY A 3 REMARK 465 ALA A 4 REMARK 465 ASP A 5 REMARK 465 ARG A 6 REMARK 465 SER A 7 REMARK 465 PRO A 8 REMARK 465 ASN A 9 REMARK 465 ALA A 10 REMARK 465 GLY A 11 REMARK 465 ALA A 12 REMARK 465 ALA A 13 REMARK 465 PRO A 14 REMARK 465 ASP A 15 REMARK 465 SER A 16 REMARK 465 ALA A 17 REMARK 465 PRO A 18 REMARK 465 GLY A 19 REMARK 465 GLN A 20 REMARK 465 ALA A 21 REMARK 465 ALA A 22 REMARK 465 VAL A 23 REMARK 465 LEU A 282 REMARK 465 GLU A 283 REMARK 465 HIS A 284 REMARK 465 HIS A 285 REMARK 465 HIS A 286 REMARK 465 HIS A 287 REMARK 465 HIS A 288 REMARK 465 HIS A 289 REMARK 465 MET B 1 REMARK 465 SER B 2 REMARK 465 GLY B 3 REMARK 465 ALA B 4 REMARK 465 ASP B 5 REMARK 465 ARG B 6 REMARK 465 SER B 7 REMARK 465 PRO B 8 REMARK 465 ASN B 9 REMARK 465 ALA B 10 REMARK 465 GLY B 11 REMARK 465 ALA B 12 REMARK 465 ALA B 13 REMARK 465 LEU B 282 REMARK 465 GLU B 283 REMARK 465 HIS B 284 REMARK 465 HIS B 285 REMARK 465 HIS B 286 REMARK 465 HIS B 287 REMARK 465 HIS B 288 REMARK 465 HIS B 289 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 101 147.46 -173.66 REMARK 500 SER A 169 142.69 -39.41 REMARK 500 ASP A 267 -173.42 -172.91 REMARK 500 TYR B 27 0.19 -64.14 REMARK 500 CYS B 183 -68.91 -104.98 REMARK 500 ALA B 224 58.88 -144.78 REMARK 500 ASP B 267 -179.05 -174.21 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SAH A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SAH B 1301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE OTR A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE OTR B 1401 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1HNN RELATED DB: PDB REMARK 900 RELATED ID: 1N7I RELATED DB: PDB REMARK 900 RELATED ID: 1N7J RELATED DB: PDB REMARK 900 RELATED ID: 1YZ3 RELATED DB: PDB REMARK 900 RELATED ID: 2AN3 RELATED DB: PDB REMARK 900 RELATED ID: 2AN5 RELATED DB: PDB DBREF 2AN4 A 1 282 UNP P11086 PNMT_HUMAN 1 282 DBREF 2AN4 B 1 282 UNP P11086 PNMT_HUMAN 1 282 SEQADV 2AN4 GLU A 283 UNP P11086 EXPRESSION TAG SEQADV 2AN4 HIS A 284 UNP P11086 EXPRESSION TAG SEQADV 2AN4 HIS A 285 UNP P11086 EXPRESSION TAG SEQADV 2AN4 HIS A 286 UNP P11086 EXPRESSION TAG SEQADV 2AN4 HIS A 287 UNP P11086 EXPRESSION TAG SEQADV 2AN4 HIS A 288 UNP P11086 EXPRESSION TAG SEQADV 2AN4 HIS A 289 UNP P11086 EXPRESSION TAG SEQADV 2AN4 GLU B 283 UNP P11086 EXPRESSION TAG SEQADV 2AN4 HIS B 284 UNP P11086 EXPRESSION TAG SEQADV 2AN4 HIS B 285 UNP P11086 EXPRESSION TAG SEQADV 2AN4 HIS B 286 UNP P11086 EXPRESSION TAG SEQADV 2AN4 HIS B 287 UNP P11086 EXPRESSION TAG SEQADV 2AN4 HIS B 288 UNP P11086 EXPRESSION TAG SEQADV 2AN4 HIS B 289 UNP P11086 EXPRESSION TAG SEQRES 1 A 289 MET SER GLY ALA ASP ARG SER PRO ASN ALA GLY ALA ALA SEQRES 2 A 289 PRO ASP SER ALA PRO GLY GLN ALA ALA VAL ALA SER ALA SEQRES 3 A 289 TYR GLN ARG PHE GLU PRO ARG ALA TYR LEU ARG ASN ASN SEQRES 4 A 289 TYR ALA PRO PRO ARG GLY ASP LEU CYS ASN PRO ASN GLY SEQRES 5 A 289 VAL GLY PRO TRP LYS LEU ARG CYS LEU ALA GLN THR PHE SEQRES 6 A 289 ALA THR GLY GLU VAL SER GLY ARG THR LEU ILE ASP ILE SEQRES 7 A 289 GLY SER GLY PRO THR VAL TYR GLN LEU LEU SER ALA CYS SEQRES 8 A 289 SER HIS PHE GLU ASP ILE THR MET THR ASP PHE LEU GLU SEQRES 9 A 289 VAL ASN ARG GLN GLU LEU GLY ARG TRP LEU GLN GLU GLU SEQRES 10 A 289 PRO GLY ALA PHE ASN TRP SER MET TYR SER GLN HIS ALA SEQRES 11 A 289 CYS LEU ILE GLU GLY LYS GLY GLU CYS TRP GLN ASP LYS SEQRES 12 A 289 GLU ARG GLN LEU ARG ALA ARG VAL LYS ARG VAL LEU PRO SEQRES 13 A 289 ILE ASP VAL HIS GLN PRO GLN PRO LEU GLY ALA GLY SER SEQRES 14 A 289 PRO ALA PRO LEU PRO ALA ASP ALA LEU VAL SER ALA PHE SEQRES 15 A 289 CYS LEU GLU ALA VAL SER PRO ASP LEU ALA SER PHE GLN SEQRES 16 A 289 ARG ALA LEU ASP HIS ILE THR THR LEU LEU ARG PRO GLY SEQRES 17 A 289 GLY HIS LEU LEU LEU ILE GLY ALA LEU GLU GLU SER TRP SEQRES 18 A 289 TYR LEU ALA GLY GLU ALA ARG LEU THR VAL VAL PRO VAL SEQRES 19 A 289 SER GLU GLU GLU VAL ARG GLU ALA LEU VAL ARG SER GLY SEQRES 20 A 289 TYR LYS VAL ARG ASP LEU ARG THR TYR ILE MET PRO ALA SEQRES 21 A 289 HIS LEU GLN THR GLY VAL ASP ASP VAL LYS GLY VAL PHE SEQRES 22 A 289 PHE ALA TRP ALA GLN LYS VAL GLY LEU GLU HIS HIS HIS SEQRES 23 A 289 HIS HIS HIS SEQRES 1 B 289 MET SER GLY ALA ASP ARG SER PRO ASN ALA GLY ALA ALA SEQRES 2 B 289 PRO ASP SER ALA PRO GLY GLN ALA ALA VAL ALA SER ALA SEQRES 3 B 289 TYR GLN ARG PHE GLU PRO ARG ALA TYR LEU ARG ASN ASN SEQRES 4 B 289 TYR ALA PRO PRO ARG GLY ASP LEU CYS ASN PRO ASN GLY SEQRES 5 B 289 VAL GLY PRO TRP LYS LEU ARG CYS LEU ALA GLN THR PHE SEQRES 6 B 289 ALA THR GLY GLU VAL SER GLY ARG THR LEU ILE ASP ILE SEQRES 7 B 289 GLY SER GLY PRO THR VAL TYR GLN LEU LEU SER ALA CYS SEQRES 8 B 289 SER HIS PHE GLU ASP ILE THR MET THR ASP PHE LEU GLU SEQRES 9 B 289 VAL ASN ARG GLN GLU LEU GLY ARG TRP LEU GLN GLU GLU SEQRES 10 B 289 PRO GLY ALA PHE ASN TRP SER MET TYR SER GLN HIS ALA SEQRES 11 B 289 CYS LEU ILE GLU GLY LYS GLY GLU CYS TRP GLN ASP LYS SEQRES 12 B 289 GLU ARG GLN LEU ARG ALA ARG VAL LYS ARG VAL LEU PRO SEQRES 13 B 289 ILE ASP VAL HIS GLN PRO GLN PRO LEU GLY ALA GLY SER SEQRES 14 B 289 PRO ALA PRO LEU PRO ALA ASP ALA LEU VAL SER ALA PHE SEQRES 15 B 289 CYS LEU GLU ALA VAL SER PRO ASP LEU ALA SER PHE GLN SEQRES 16 B 289 ARG ALA LEU ASP HIS ILE THR THR LEU LEU ARG PRO GLY SEQRES 17 B 289 GLY HIS LEU LEU LEU ILE GLY ALA LEU GLU GLU SER TRP SEQRES 18 B 289 TYR LEU ALA GLY GLU ALA ARG LEU THR VAL VAL PRO VAL SEQRES 19 B 289 SER GLU GLU GLU VAL ARG GLU ALA LEU VAL ARG SER GLY SEQRES 20 B 289 TYR LYS VAL ARG ASP LEU ARG THR TYR ILE MET PRO ALA SEQRES 21 B 289 HIS LEU GLN THR GLY VAL ASP ASP VAL LYS GLY VAL PHE SEQRES 22 B 289 PHE ALA TRP ALA GLN LYS VAL GLY LEU GLU HIS HIS HIS SEQRES 23 B 289 HIS HIS HIS HET PO4 A 501 5 HET SAH A 301 26 HET OTR A 401 11 HET SAH B1301 26 HET OTR B1401 11 HETNAM PO4 PHOSPHATE ION HETNAM SAH S-ADENOSYL-L-HOMOCYSTEINE HETNAM OTR 4-(2R-AMINO-1-HYDROXYETHYL)PHENOL HETSYN OTR R-OCTOPAMINE FORMUL 3 PO4 O4 P 3- FORMUL 4 SAH 2(C14 H20 N6 O5 S) FORMUL 5 OTR 2(C8 H11 N O2) FORMUL 8 HOH *254(H2 O) HELIX 1 1 SER A 25 PHE A 30 5 6 HELIX 2 2 GLU A 31 TYR A 40 1 10 HELIX 3 3 GLY A 52 THR A 67 1 16 HELIX 4 4 VAL A 84 LEU A 88 5 5 HELIX 5 5 ALA A 90 PHE A 94 5 5 HELIX 6 6 LEU A 103 GLN A 115 1 13 HELIX 7 7 TRP A 123 GLY A 135 1 13 HELIX 8 8 CYS A 139 ARG A 150 1 12 HELIX 9 9 CYS A 183 SER A 188 1 6 HELIX 10 10 ASP A 190 THR A 203 1 14 HELIX 11 11 SER A 235 SER A 246 1 12 HELIX 12 12 PRO A 259 GLN A 263 5 5 HELIX 13 13 SER B 16 TYR B 27 1 12 HELIX 14 14 GLN B 28 PHE B 30 5 3 HELIX 15 15 GLU B 31 ALA B 41 1 11 HELIX 16 16 GLY B 52 ALA B 66 1 15 HELIX 17 17 VAL B 84 LEU B 88 5 5 HELIX 18 18 LEU B 103 GLN B 115 1 13 HELIX 19 19 TRP B 123 GLY B 135 1 13 HELIX 20 20 CYS B 139 ARG B 150 1 12 HELIX 21 21 CYS B 183 SER B 188 1 6 HELIX 22 22 ASP B 190 THR B 203 1 14 HELIX 23 23 SER B 235 SER B 246 1 12 HELIX 24 24 PRO B 259 GLN B 263 5 5 SHEET 1 A 7 VAL A 151 LEU A 155 0 SHEET 2 A 7 ASP A 96 THR A 100 1 N MET A 99 O ARG A 153 SHEET 3 A 7 THR A 74 ILE A 78 1 N ASP A 77 O THR A 98 SHEET 4 A 7 ALA A 175 ALA A 181 1 O VAL A 179 N ILE A 78 SHEET 5 A 7 LEU A 205 LEU A 217 1 O HIS A 210 N LEU A 178 SHEET 6 A 7 GLY A 271 LYS A 279 -1 O ALA A 275 N LEU A 213 SHEET 7 A 7 TYR A 248 ILE A 257 -1 N ASP A 252 O TRP A 276 SHEET 1 B 2 TRP A 221 ALA A 224 0 SHEET 2 B 2 ALA A 227 THR A 230 -1 O LEU A 229 N TYR A 222 SHEET 1 C 7 VAL B 151 PRO B 156 0 SHEET 2 C 7 ASP B 96 ASP B 101 1 N MET B 99 O ARG B 153 SHEET 3 C 7 THR B 74 ILE B 78 1 N LEU B 75 O THR B 98 SHEET 4 C 7 ALA B 175 ALA B 181 1 O VAL B 179 N ILE B 78 SHEET 5 C 7 LEU B 205 LEU B 217 1 O HIS B 210 N LEU B 178 SHEET 6 C 7 GLY B 271 LYS B 279 -1 O GLY B 271 N LEU B 217 SHEET 7 C 7 TYR B 248 ILE B 257 -1 N ASP B 252 O TRP B 276 SHEET 1 D 2 TRP B 221 ALA B 224 0 SHEET 2 D 2 ALA B 227 THR B 230 -1 O LEU B 229 N TYR B 222 SSBOND 1 CYS A 48 CYS B 139 1555 1555 2.04 SSBOND 2 CYS A 139 CYS B 48 1555 1555 2.04 CISPEP 1 PRO A 42 PRO A 43 0 0.39 CISPEP 2 LEU A 173 PRO A 174 0 -0.30 CISPEP 3 PRO B 42 PRO B 43 0 0.35 CISPEP 4 LEU B 173 PRO B 174 0 -0.03 SITE 1 AC1 4 ARG A 240 VAL A 250 ARG A 251 ASP B 252 SITE 1 AC2 20 TYR A 27 TYR A 35 TYR A 40 GLY A 79 SITE 2 AC2 20 SER A 80 GLY A 81 THR A 83 TYR A 85 SITE 3 AC2 20 ASP A 101 PHE A 102 LEU A 103 ASN A 106 SITE 4 AC2 20 ASP A 158 VAL A 159 HIS A 160 ALA A 181 SITE 5 AC2 20 PHE A 182 CYS A 183 VAL A 187 HOH A 549 SITE 1 AC3 21 TYR B 27 TYR B 35 TYR B 40 GLY B 79 SITE 2 AC3 21 SER B 80 GLY B 81 THR B 83 TYR B 85 SITE 3 AC3 21 ASP B 101 PHE B 102 LEU B 103 ASN B 106 SITE 4 AC3 21 ILE B 157 ASP B 158 VAL B 159 ALA B 181 SITE 5 AC3 21 PHE B 182 CYS B 183 VAL B 187 HOH B1414 SITE 6 AC3 21 HOH B1424 SITE 1 AC4 12 TYR A 35 ASN A 39 ARG A 44 LYS A 57 SITE 2 AC4 12 PHE A 182 GLU A 219 TYR A 222 MET A 258 SITE 3 AC4 12 ASP A 267 HOH A 507 HOH A 551 HOH A 578 SITE 1 AC5 11 TYR B 35 ARG B 44 VAL B 53 PHE B 182 SITE 2 AC5 11 GLU B 219 TYR B 222 MET B 258 ASP B 267 SITE 3 AC5 11 HOH B1404 HOH B1414 HOH B1499 CRYST1 93.470 93.470 187.740 90.00 90.00 90.00 P 43 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010699 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010699 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005327 0.00000